Healthcare -
Biotechnology - NASDAQ - US
$ 29.74
-2.14 %
$ 3.7 B
Market Cap
-14.65
P/E
APLS - NET CHANGE IN CASH
Net Change in Cash APLS - Apellis Pharmaceuticals, Inc.
-201 M
LAST VALUE
-92.03%
2 YEAR CAGR
-217.51%
5 YEAR CAGR
-49.30%
10 YEAR CAGR